New treatment for chronic sinusitis with nasal polyps
Treatments studied
This trial tests an investigational medication called AK139 for people with chronic sinusitis and nasal polyps. The treatment aims to reduce nasal congestion and polyp size, potentially improving symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age: 18 to 75 years old
- Have nasal polyps in both nostrils with a total score of at least 5 (moderate to severe)
- Have ongoing nasal congestion that is moderate or severe
- Have used a steroid nasal spray for at least 4 weeks before the study starts
- Have previously needed steroid pills, been unable to take them, or had surgery for polyps
- No nasal surgery within the last 6 months, and no other significant sinus conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
This trial tests an injection called LP-003 for people with nasal polyps and chronic sinusitis. It aims to reduce symptoms like nasal congestion and improve quality of life. You may qualify if you have tried other treatments and still have symptoms.
This trial tests a new injectable medicine (lebrikizumab) for people with chronic sinusitis and nasal polyps that steroid treatments haven't controlled. It aims to reduce polyp size and improve breathing, smell, and congestion.
This trial compares a newer biologic drug (anti-IL-5) plus simple polyp removal to a more extensive sinus surgery. It's for people with chronic sinusitis and nasal polyps who haven't gotten better with standard treatments.
This study tests a new drug called BBT002 in healthy people and in patients with chronic sinusitis and nasal polyps, with or without asthma. It aims to see if the drug is safe and effective for reducing symptoms.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.